Li, Yan <br/><br/>
Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751.  [electronic resource] 

 -  Asian Pacific journal of cancer prevention : APJCP  2011 
 - 739-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2476-762X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Large Cell--drug therapy<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Codon--genetics<br/>DNA, Neoplasm--genetics<br/>DNA-Binding Proteins--genetics<br/>Deoxycytidine--administration & dosage<br/>Docetaxel<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Paclitaxel--administration & dosage<br/>Polymerase Chain Reaction<br/>Polymorphism, Restriction Fragment Length<br/>Polymorphism, Single Nucleotide--genetics<br/>Survival Rate<br/>Taxoids--administration & dosage<br/>Treatment Outcome<br/>X-ray Repair Cross Complementing Protein 1<br/>Xeroderma Pigmentosum Group D Protein--genetics<br/>Gemcitabine